Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 457

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 457
---
 10-year term and an exercise price of $14.05. At December 31, 2024
and 2023, respectively, 45,386 of these warrants are outstanding and the intrinsic value of these warrants is $0.

During April
2024, the Company issued 1,557,592 warrants to investors in connection with the sale of common stock. At December 31, 2024, 1,557,592 of
these warrants are outstanding and are exercisable for cash at a weighted average price of $9.59 per share. The intrinsic value of
these warrants was $0 as of December 31, 2024.

During September
2024, the Company issued 2,341,260 warrants to investors in connection with the sale of common stock. At December 31, 2024, 2,341,260 of
these warrants are outstanding and are exercisable for cash at a weighted average price of $6.40 per share. The intrinsic value of
these warrants was $0 as of December 31, 2024.

During the year ended December 31, 2023, a third
party exercised 28,688 warrants on a cashless basis in exchange for 4,781 shares of common stock.

Stock-based Compensation by Class of Expense

The following summarizes the components of stock-based
compensation expense in the consolidated statements of operations for the years ended December 31, 2024 and 2023, respectively:

    (in thousands) 
    Year Ended December 31, 2024  
    Year Ended December 31, 2023 
  
    Research and development 
    $3,037  
    $2,743 
  
    General and administrative 
     4,568  
     4,625 
  
    Total 
    $7,605  
    $7,368 

Shareholder Rights Agreement

On December 30, 2020, the Board of Directors (the
“Board”) of the Company approved and adopted a Rights Agreement, dated as of December 30, 2020, by and between the Company
and VStock Transfer, LLC, as rights agent, pursuant to which the Board declared a dividend of one preferred share purchase right (each,
a “Right”) for each outstanding share of the Company’s common stock held by stockholders as of the close of business
on January 11,